✦ LIBER ✦

Response from the authors to: Identification of paroxysmal atrial fibrillation also for primary prevention of embolic stroke

✍ Scribed by Anil-Martin Sinha; Johannes Brachmann; Hans-Christoph Diener; Carlos A. Morillo; Tommaso Sanna; Richard A. Bernstein; Vincenzo Di Lazzaro; Rod Passman; Marilyn Rymer; Frank Beckers

Book ID: 116192292
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 62 KB
Volume: 160
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2010.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of paroxysmal atrial fibr

Identification of paroxysmal atrial fibrillation also for primary prevention of embolic stroke

✍ Oscar M.P. Jolobe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

900 Efficacy and safety of apixaban comp

900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial

✍ J. Ezekowitz; P. Dorian; C. Granger; J. Alexander; R. Lopes; M. Hanna; M. Gerald 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 72 KB

For people with non-valvular atrial fibr

For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding

✍ Sherwood, M.; Piccini, J. P. 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 68 KB

Oral direct thrombin inhibitor AZD0837 f

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB